<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD00450000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P15056</UniProt_ID>
  <Seq_Length>766</Seq_Length>
  <Molecule_Weight>84437</Molecule_Weight>
  <KEGG_ID>hsa:673</KEGG_ID>
  <Orthology_ID>K04365</Orthology_ID>
  <EBI_ID>EBI-365980</EBI_ID>
  <Function_Summary>Involved in the transduction of mitogenic signals from the cell membrane to the nucleus. May play a role in the postsynaptic responses of hippocampal neuron.</Function_Summary>
  <Catalytic_Mechanism>ATP + a protein = ADP + a phosphoprotein.</Catalytic_Mechanism>
  <Pfam_ID>PF00130:C1_1@@PF07714:Pkinase_Tyr@@PF02196:RBD</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>60</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>P94</Alias>
      <Alias>B-Raf protein kinase</Alias>
      <Alias>V-Raf murine sarcoma viral oncogene homolog B1</Alias>
      <Alias>Proto-oncogene B-Raf</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.</Detail>
      <Keyword>Transferase activity</Keyword>
      <Ontology_ID>GO:0016740</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any metal ion.</Detail>
      <Keyword>Metal ion binding</Keyword>
      <Ontology_ID>GO:0046872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.</Detail>
      <Keyword>Nucleotide binding</Keyword>
      <Ontology_ID>GO:0000166</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.</Detail>
      <Keyword>Kinase activity</Keyword>
      <Ontology_ID>GO:0016301</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.</Detail>
      <Keyword>ATP binding</Keyword>
      <Ontology_ID>GO:0005524</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.</Detail>
      <Keyword>Protein serine/threonine kinase activity</Keyword>
      <Ontology_ID>GO:0004674</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>595</Position>
      <Original>Phe</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>600</Position>
      <Original>Val</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>501</Position>
      <Original>Glu</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>525</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>469</Position>
      <Original>Gly</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>246</Position>
      <Original>Ala</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>469</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>245</Position>
      <Original>Leu</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>709</Position>
      <Original>Gln</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>241</Position>
      <Original>Thr</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>241</Position>
      <Original>Thr</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>464</Position>
      <Original>Gly</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>597</Position>
      <Original>Leu</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>601</Position>
      <Original>Lys</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>462</Position>
      <Original>Arg</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>580</Position>
      <Original>Asn</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>463</Position>
      <Original>Ile</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>469</Position>
      <Original>Gly</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>466</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>586</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>275</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>244</Position>
      <Original>Thr</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>485</Position>
      <Original>Leu</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>581</Position>
      <Original>Asn</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>600</Position>
      <Original>Val</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>468</Position>
      <Original>Phe</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>597</Position>
      <Original>Leu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>594</Position>
      <Original>Asp</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>596</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>638</Position>
      <Original>Asp</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>469</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>467</Position>
      <Original>Ser</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>601</Position>
      <Original>Lys</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>499</Position>
      <Original>Lys</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>466</Position>
      <Original>Gly</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>499</Position>
      <Original>Lys</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>466</Position>
      <Original>Gly</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>241</Position>
      <Original>Thr</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>596</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>262</Position>
      <Original>Gln</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>501</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>531</Position>
      <Original>Trp</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>581</Position>
      <Original>Asn</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>257</Position>
      <Original>Gln</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>301</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>464</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>599</Position>
      <Original>Thr</Original>
      <Variation>Arg</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine.</Detail>
      <Keyword>Positive regulation of peptidyl-serine phosphorylation</Keyword>
      <Ontology_ID>GO:0033138</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A process which directly inhibits any of the steps required for cell death by apoptosis.</Detail>
      <Keyword>Anti-apoptosis</Keyword>
      <Ontology_ID>GO:0006916</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.</Detail>
      <Keyword>Positive regulation of ERK1 and ERK2 cascade</Keyword>
      <Ontology_ID>GO:0070374</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of the nerve growth factor receptor binding to one of its physiological ligands.</Detail>
      <Keyword>Nerve growth factor receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0048011</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Morphogenesis of an organ. An organ is defined as a tissue or set of tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.</Detail>
      <Keyword>Organ morphogenesis</Keyword>
      <Ontology_ID>GO:0009887</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands.</Detail>
      <Keyword>Fibroblast growth factor receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0008543</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any series of molecular signals in which a small monomeric GTPase relays one or more of the signals.</Detail>
      <Keyword>Small GTPase mediated signal transduction</Keyword>
      <Ontology_ID>GO:0007264</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Some protein processing events may be included when they are required to form an active form of a product from an inactive precursor form.</Detail>
      <Keyword>Positive regulation of gene expression</Keyword>
      <Ontology_ID>GO:0010628</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process of communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse.</Detail>
      <Keyword>Synaptic transmission</Keyword>
      <Ontology_ID>GO:0007268</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>419</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>753</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>396</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>418</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>401</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>399</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>2</Position>
      <PTM_Type>N-acetylalanine</PTM_Type>
    </PTM>
    <PTM>
      <Position>365</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>373</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>750</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>447</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>151</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>729</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>465</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>614</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>446</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MAALSGGGGGGAEPGQALFNGDMEPEAGAGAGAAASSAADPAIPEEVWNIKQMIKLTQEHIEALLDKFGGEHNPPSIYLEAYEEYTSKLDALQQREQQLLESLGNGTDFSVSSSASMDTVTSSSSSSLSVLPSSLSVFQNPTDVARSNPKSPQKPIVRVFLPNKQRTVVPARCGVTVRDSLKKALMMRGLIPECCAVYRIQDGEKKPIGWDTDISWLTGEELHVEVLENVPLTTHNFVRKTFFTLAFCDFCRKLLFQGFRCQTCGYKFHQRCSTEVPLMCVNYDQLDLLFVSKFFEHHPIPQEEASLAETALTSGSSPSAPASDSIGPQILTSPSPSKSIPIPQPFRPADEDHRNQFGQRDRSSSAPNVHINTIEPVNIDDLIRDQGFRGDGGSTTGLSATPPASLPGSLTNVKALQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH</Protein_Seq>
    <DNA_Seq>CGCCTCCCGGCCCCCTCCCCGCCCGACAGCGGCCGCTCGGGCCCCGGCTCTCGGTTATAAGATGGCGGCGCTGAGCGGTGGCGGTGGTGGCGGCGCGGAGCCGGGCCAGGCTCTGTTCAACGGGGACATGGAGCCCGAGGCCGGCGCCGGCGCCGGCGCCGCGGCCTCTTCGGCTGCGGACCCTGCCATTCCGGAGGAGGTGTGGAATATCAAACAAATGATTAAGTTGACACAGGAACATATAGAGGCCCTATTGGACAAATTTGGTGGGGAGCATAATCCACCATCAATATATCTGGAGGCCTATGAAGAATACACCAGCAAGCTAGATGCACTCCAACAAAGAGAACAACAGTTATTGGAATCTCTGGGGAACGGAACTGATTTTTCTGTTTCTAGCTCTGCATCAATGGATACCGTTACATCTTCTTCCTCTTCTAGCCTTTCAGTGCTACCTTCATCTCTTTCAGTTTTTCAAAATCCCACAGATGTGGCACGGAGCAACCCCAAGTCACCACAAAAACCTATCGTTAGAGTCTTCCTGCCCAACAAACAGAGGACAGTGGTACCTGCAAGGTGTGGAGTTACAGTCCGAGACAGTCTAAAGAAAGCACTGATGATGAGAGGTCTAATCCCAGAGTGCTGTGCTGTTTACAGAATTCAGGATGGAGAGAAGAAACCAATTGGTTGGGACACTGATATTTCCTGGCTTACTGGAGAAGAATTGCATGTGGAAGTGTTGGAGAATGTTCCACTTACAACACACAACTTTGTACGAAAAACGTTTTTCACCTTAGCATTTTGTGACTTTTGTCGAAAGCTGCTTTTCCAGGGTTTCCGCTGTCAAACATGTGGTTATAAATTTCACCAGCGTTGTAGTACAGAAGTTCCACTGATGTGTGTTAATTATGACCAACTTGATTTGCTGTTTGTCTCCAAGTTCTTTGAACACCACCCAATACCACAGGAAGAGGCGTCCTTAGCAGAGACTGCCCTAACATCTGGATCATCCCCTTCCGCACCCGCCTCGGACTCTATTGGGCCCCAAATTCTCACCAGTCCGTCTCCTTCAAAATCCATTCCAATTCCACAGCCCTTCCGACCAGCAGATGAAGATCATCGAAATCAATTTGGGCAACGAGACCGATCCTCATCAGCTCCCAATGTGCATATAAACACAATAGAACCTGTCAATATTGATGACTTGATTAGAGACCAAGGATTTCGTGGTGATGGAGGATCAACCACAGGTTTGTCTGCTACCCCCCCTGCCTCATTACCTGGCTCACTAACTAACGTGAAAGCCTTACAGAAATCTCCAGGACCTCAGCGAGAAAGGAAGTCATCTTCATCCTCAGAAGACAGGAATCGAATGAAAACACTTGGTAGACGGGACTCGAGTGATGATTGGGAGATTCCTGATGGGCAGATTACAGTGGGACAAAGAATTGGATCTGGATCATTTGGAACAGTCTACAAGGGAAAGTGGCATGGTGATGTGGCAGTGAAAATGTTGAATGTGACAGCACCTACACCTCAGCAGTTACAAGCCTTCAAAAATGAAGTAGGAGTACTCAGGAAAACACGACATGTGAATATCCTACTCTTCATGGGCTATTCCACAAAGCCACAACTGGCTATTGTTACCCAGTGGTGTGAGGGCTCCAGCTTGTATCACCATCTCCATATCATTGAGACCAAATTTGAGATGATCAAACTTATAGATATTGCACGACAGACTGCACAGGGCATGGATTACTTACACGCCAAGTCAATCATCCACAGAGACCTCAAGAGTAATAATATATTTCTTCATGAAGACCTCACAGTAAAAATAGGTGATTTTGGTCTAGCTACAGTGAAATCTCGATGGAGTGGGTCCCATCAGTTTGAACAGTTGTCTGGATCCATTTTGTGGATGGCACCAGAAGTCATCAGAATGCAAGATAAAAATCCATACAGCTTTCAGTCAGATGTATATGCATTTGGGATTGTTCTGTATGAATTGATGACTGGACAGTTACCTTATTCAAACATCAACAACAGGGACCAGATAATTTTTATGGTGGGACGAGGATACCTGTCTCCAGATCTCAGTAAGGTACGGAGTAACTGTCCAAAAGCCATGAAGAGATTAATGGCAGAGTGCCTCAAAAAGAAAAGAGATGAGAGACCACTCTTTCCCCAAATTCTCGCCTCTATTGAGCTGCTGGCCCGCTCATTGCCAAAAATTCACCGCAGTGCATCAGAACCCTCCTTGAATCGGGCTGGTTTCCAAACAGAGGATTTTAGTCTATATGCTTGTGCTTCTCCAAAAACACCCATCCAGGCAGGGGGATATGGTGCGTTTCCTGTCCACTGAAACAAATGAGTGAGAGAGTTCAGGAGAGTAGCAACAAAAGGAAAATAAATGAACATATGTTTGCTTATATGTTAAATTGAATAAAATACTCTCTTTTTTTTTAAGGTGGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACC</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Testis</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Brain</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>BRAF</Gene_Name>
    <Gene_Alias>BRAF1; RAFB1</Gene_Alias>
    <Gene_ID>673</Gene_ID>
    <Genbank_ACCN>NM_004333</Genbank_ACCN>
    <Protein_ACCN>NP_004324</Protein_ACCN>
    <HGNC_ID>1097</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/673</Gene_URL>
    <UCSC_ID>uc003vwc.4</UCSC_ID>
    <EMBL_ID>ENSG00000157764</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>P04049</Uniprot_ID>
      <Gene_Name>RAF1</Gene_Name>
      <EBI_ID>EBI-365996</EBI_ID>
      <PPI_EBI_URL>EBI-365980,EBI-365996</PPI_EBI_URL>
      <Experiment_Number>30</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Thyroid Cancer</Disease_Name>
      <Disease_Detail>Thyroid Cancer</Disease_Detail>
      <Disease_DB>THY028</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/thyroid_cancer?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Struma Ovarii</Disease_Name>
      <Disease_Detail>Struma Ovarii</Disease_Detail>
      <Disease_DB>STR021</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/struma_ovarii?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Thyroid Carcinoma, Papillary, Somatic</Disease_Name>
      <Disease_Detail>Thyroid Cancer</Disease_Detail>
      <Disease_DB>THY093</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/thyroid_carcinoma_papillary_somatic?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Melanoma of Soft Parts</Disease_Name>
      <Disease_Detail>Melanoma</Disease_Detail>
      <Disease_DB>MLN057</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/melanoma_of_soft_parts?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Noonan Syndrome</Disease_Name>
      <Disease_Detail>Noonan Syndrome</Disease_Detail>
      <Disease_DB>NNN003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/noonan_syndrome?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Spitz Nevus</Disease_Name>
      <Disease_Detail>Spitz Nevus</Disease_Detail>
      <Disease_DB>SPT007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/spitz_nevus?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Noonan Syndrome 7</Disease_Name>
      <Disease_Detail>Noonan Syndrome</Disease_Detail>
      <Disease_DB>NNN020</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/noonan_syndrome_7?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Non-Hodgkin Lymphoma</Disease_Name>
      <Disease_Detail>Non-Hodgkin Lymphoma</Disease_Detail>
      <Disease_DB>NNH001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/non_hodgkin_lymphoma?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Lung Cancer, Somatic</Disease_Name>
      <Disease_Detail>Lung Cancer</Disease_Detail>
      <Disease_DB>LNG061</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/lung_cancer_somatic?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Erdheim-Chester Disease</Disease_Name>
      <Disease_Detail>Erdheim-Chester Disease</Disease_Detail>
      <Disease_DB>ERD001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/erdheim_chester_disease?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cardiofaciocutaneous Syndrome</Disease_Name>
      <Disease_Detail>Cardiofaciocutaneous Syndrome</Disease_Detail>
      <Disease_DB>CRD013</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cardiofaciocutaneous_syndrome?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Lung Adenoma</Disease_Name>
      <Disease_Detail>Lung Cancer</Disease_Detail>
      <Disease_DB>LNG030</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/lung_adenoma?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Perineurioma</Disease_Name>
      <Disease_Detail>Perineurioma</Disease_Detail>
      <Disease_DB>PRN022</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/perineurioma?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cystadenoma</Disease_Name>
      <Disease_Detail>Cystadenoma</Disease_Detail>
      <Disease_DB>CYS009</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cystadenoma?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cardiofaciocutaneous Syndrome 3</Disease_Name>
      <Disease_Detail>Cardiofaciocutaneous Syndrome</Disease_Detail>
      <Disease_DB>CRD164</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cardiofaciocutaneous_syndrome_3?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hyperplastic Polyposis Syndrome</Disease_Name>
      <Disease_Detail>Hyperplastic Polyposis Syndrome</Disease_Detail>
      <Disease_DB>HYP466</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hyperplastic_polyposis_syndrome?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Posterior Uveal Melanoma</Disease_Name>
      <Disease_Detail>Posterior Uveal Melanoma</Disease_Detail>
      <Disease_DB>PST022</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/posterior_uveal_melanoma?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hashimoto-Pritzker Syndrome</Disease_Name>
      <Disease_Detail>Hashimoto-Pritzker Syndrome</Disease_Detail>
      <Disease_DB>HSH001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hashimoto_pritzker_syndrome?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cardiofaciocutaneous Syndrome 2</Disease_Name>
      <Disease_Detail>Cardiofaciocutaneous Syndrome</Disease_Detail>
      <Disease_DB>CRD163</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cardiofaciocutaneous_syndrome_2?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cardiofaciocutaneous Syndrome 4</Disease_Name>
      <Disease_Detail>Cardiofaciocutaneous Syndrome</Disease_Detail>
      <Disease_DB>CRD167</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cardiofaciocutaneous_syndrome_4?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Atypical Mole Syndrome</Disease_Name>
      <Disease_Detail>Atypical Mole Syndrome</Disease_Detail>
      <Disease_DB>ATY019</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/atypical_mole_syndrome?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Sarcoma</Disease_Name>
      <Disease_Detail>Sarcoma</Disease_Detail>
      <Disease_DB>SRC014</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/sarcoma?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Lung Cancer</Disease_Name>
      <Disease_Detail>Lung Cancer</Disease_Detail>
      <Disease_DB>LNG032</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/lung_cancer?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Adenocarcinoma</Disease_Name>
      <Disease_Detail>Adenocarcinoma</Disease_Detail>
      <Disease_DB>ADN016</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/adenocarcinoma?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Colonic Benign Neoplasm</Disease_Name>
      <Disease_Detail>Colon Cancer</Disease_Detail>
      <Disease_DB>CLN045</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/colonic_benign_neoplasm?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Nonsmall Cell Lung Cancer, Somatic</Disease_Name>
      <Disease_Detail>Nonsmall Cell Lung Cancer</Disease_Detail>
      <Disease_DB>NNS020</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/nonsmall_cell_lung_cancer_somatic?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Melanoma</Disease_Name>
      <Disease_Detail>Melanoma</Disease_Detail>
      <Disease_DB>MLN008</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/melanoma?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Leopard Syndrome 3</Disease_Name>
      <Disease_Detail>Leopard Syndrome</Disease_Detail>
      <Disease_DB>LPR007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/leopard_syndrome_3?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Mature B-Cell Neoplasm</Disease_Name>
      <Disease_Detail>Mature B-Cell Neoplasm</Disease_Detail>
      <Disease_DB>MTR008</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/mature_b_cell_neoplasm?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Colonic Adenoma Recurrence, Reduced Risk of</Disease_Name>
      <Disease_Detail>Colon Cancer</Disease_Detail>
      <Disease_DB>CLN029</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/colonic_adenoma_recurrence_reduced_risk_of?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Familial Melanoma</Disease_Name>
      <Disease_Detail>Familial Melanoma</Disease_Detail>
      <Disease_DB>FML024</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/familial_melanoma?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Follicular Thyroid Carcinoma</Disease_Name>
      <Disease_Detail>Follicular Thyroid Carcinoma</Disease_Detail>
      <Disease_DB>FLL032</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/follicular_thyroid_carcinoma?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Uveal Melanoma</Disease_Name>
      <Disease_Detail>Uveal Melanoma</Disease_Detail>
      <Disease_DB>UVL004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/uveal_melanoma?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Melanoma, Malignant, Somatic</Disease_Name>
      <Disease_Detail>Melanoma</Disease_Detail>
      <Disease_DB>MLN020</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/melanoma_malignant_somatic?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Leopard Syndrome 1</Disease_Name>
      <Disease_Detail>Leopard Syndrome</Disease_Detail>
      <Disease_DB>LPR012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/leopard_syndrome_1?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Braf-Related Cardiofaciocutaneous Syndrome</Disease_Name>
      <Disease_Detail>Braf-Related Cardiofaciocutaneous Syndrome</Disease_Detail>
      <Disease_DB>BRF001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/braf_related_cardiofaciocutaneous_syndrome?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Lung Cancer, Protection Against</Disease_Name>
      <Disease_Detail>Lung Cancer</Disease_Detail>
      <Disease_DB>LNG068</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/lung_cancer_protection_against?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Leopard Syndrome</Disease_Name>
      <Disease_Detail>Leopard Syndrome</Disease_Detail>
      <Disease_DB>LPR002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/leopard_syndrome?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hodgkin's Lymphoma</Disease_Name>
      <Disease_Detail>Hodgkin's Lymphoma</Disease_Detail>
      <Disease_DB>HDG007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hodgkins_lymphoma?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Intestinal Neoplasm</Disease_Name>
      <Disease_Detail>Intestinal Neoplasm</Disease_Detail>
      <Disease_DB>INT069</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/intestinal_neoplasm?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Craniopharyngioma</Disease_Name>
      <Disease_Detail>Craniopharyngioma</Disease_Detail>
      <Disease_DB>CRN036</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/craniopharyngioma?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Colon Cancer, Somatic</Disease_Name>
      <Disease_Detail>Colon Cancer</Disease_Detail>
      <Disease_DB>CLN030</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/colon_cancer_somatic?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pulmonic Stenosis</Disease_Name>
      <Disease_Detail>Pulmonic Stenosis</Disease_Detail>
      <Disease_DB>PLM070</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pulmonic_stenosis?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Nonsmall Cell Lung Cancer, Response to Tyrosine Kinase Inhibitor in</Disease_Name>
      <Disease_Detail>Nonsmall Cell Lung Cancer</Disease_Detail>
      <Disease_DB>NNS021</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/nonsmall_cell_lung_cancer_response_to_tyrosine_kinase_inhibitor_in?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Villous Adenoma</Disease_Name>
      <Disease_Detail>Villous Adenoma</Disease_Detail>
      <Disease_DB>VLL006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/villous_adenoma?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Non-Small Cell Lung Carcinoma</Disease_Name>
      <Disease_Detail>Non-Small Cell Lung Carcinoma</Disease_Detail>
      <Disease_DB>NNS005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/non_small_cell_lung_carcinoma?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Adenocarcinoma of Lung, Response to Tyrosine Kinase Inhibitor in</Disease_Name>
      <Disease_Detail>Adenocarcinoma</Disease_Detail>
      <Disease_DB>ADN036</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/adenocarcinoma_of_lung_response_to_tyrosine_kinase_inhibitor_in?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Lymphoma, Non-Hodgkin, Somatic</Disease_Name>
      <Disease_Detail>Lymphoma</Disease_Detail>
      <Disease_DB>LYM060</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/lymphoma_non_hodgkin_somatic?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Colorectal Cancer</Disease_Name>
      <Disease_Detail>Colorectal Cancer</Disease_Detail>
      <Disease_DB>CLR023</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/colorectal_cancer?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Braf-Related Noonan Syndrome</Disease_Name>
      <Disease_Detail>Braf-Related Noonan Syndrome</Disease_Detail>
      <Disease_DB>BRF003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/braf_related_noonan_syndrome?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Lynch Syndrome</Disease_Name>
      <Disease_Detail>Lynch Syndrome</Disease_Detail>
      <Disease_DB>LYN001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/lynch_syndrome?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Colorectal Cancer, Somatic</Disease_Name>
      <Disease_Detail>Colorectal Cancer</Disease_Detail>
      <Disease_DB>CLR034</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/colorectal_cancer_somatic?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hairy Cell Leukemia</Disease_Name>
      <Disease_Detail>Hairy Cell Leukemia</Disease_Detail>
      <Disease_DB>HRY003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hairy_cell_leukemia?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pilocytic Astrocytoma</Disease_Name>
      <Disease_Detail>Pilocytic Astrocytoma</Disease_Detail>
      <Disease_DB>PLC011</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pilocytic_astrocytoma?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Noonan Syndrome 1</Disease_Name>
      <Disease_Detail>Noonan Syndrome</Disease_Detail>
      <Disease_DB>NNN008</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/noonan_syndrome_1?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Braf-Related Leopard Syndrome</Disease_Name>
      <Disease_Detail>Braf-Related Leopard Syndrome</Disease_Detail>
      <Disease_DB>BRF002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/braf_related_leopard_syndrome?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Metanephric Adenoma</Disease_Name>
      <Disease_Detail>Metanephric Adenoma</Disease_Detail>
      <Disease_DB>MTN001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/metanephric_adenoma?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Papillary Thyroid Carcinoma</Disease_Name>
      <Disease_Detail>Papillary Thyroid Carcinoma</Disease_Detail>
      <Disease_DB>PPL020</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/papillary_thyroid_carcinoma?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Familial Non-Hodgkin Lymphoma</Disease_Name>
      <Disease_Detail>Familial Non-Hodgkin Lymphoma</Disease_Detail>
      <Disease_DB>FML140</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/familial_non_hodgkin_lymphoma?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Adenocarcinoma of Lung, Somatic</Disease_Name>
      <Disease_Detail>Adenocarcinoma</Disease_Detail>
      <Disease_DB>ADN033</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/adenocarcinoma_of_lung_somatic?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Colon Cancer</Disease_Name>
      <Disease_Detail>Colon Cancer</Disease_Detail>
      <Disease_DB>CLN016</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/colon_cancer?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Nephrotic Syndrome Type 3</Disease_Name>
      <Disease_Detail>Nephrotic Syndrome</Disease_Detail>
      <Disease_DB>NPH038</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/nephrotic_syndrome_type_3?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Thyroid Carcinoma, Follicular, Somatic</Disease_Name>
      <Disease_Detail>Thyroid Cancer</Disease_Detail>
      <Disease_DB>THY059</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/thyroid_carcinoma_follicular_somatic?search=BRAF#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pleomorphic Xanthoastrocytoma</Disease_Name>
      <Disease_Detail>Pleomorphic Xanthoastrocytoma</Disease_Detail>
      <Disease_DB>PLM020</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pleomorphic_xanthoastrocytoma?search=BRAF#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Crystal structure of a BRAF kinase domain monomer</PDB_Title>
      <PDB_ID>4WO5</PDB_ID>
      <Resolution>2.83</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4WO5</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD00450023</ASD_Ligand>
      <PubMed_Title>Crystal structure of a BRAF kinase domain monomer explains basis for allosteric regulation.</PubMed_Title>
      <Author>Thevakumaran, N., et al.</Author>
      <Journal>Nat.Struct.Mol.Biol.(2015)22:37-43</Journal>
      <PubMed_ID>25437913</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>The Complex of wild-type B-RAF with Pyrazolo pyrimidine inhibitor</PDB_Title>
      <PDB_ID>3II5</PDB_ID>
      <Resolution>2.79</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3II5</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Non-hinge-binding pyrazolo[1,5-a]pyrimidines as potent B-Raf kinase inhibitors.</PubMed_Title>
      <Author>Berger DM, et al.</Author>
      <Journal>Bioorg Med Chem Lett. 2009 Dec 1;19(23):6519-23.</Journal>
      <PubMed_ID>19864136</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human B-Raf Kinase Domain bound to a Type II Pyrazolopyridine Inhibitor</PDB_Title>
      <PDB_ID>4G9C</PDB_ID>
      <Resolution>3.5</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4G9C</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD00450022</ASD_Ligand>
      <PubMed_Title>Pyrazolopyridine inhibitors of B-Raf(V600E). Part 4: Rational design and kinase selectivity profile of cell potent type II inhibitors.</PubMed_Title>
      <Author>Wenglowsky, S., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2012)22:6237-6241</Journal>
      <PubMed_ID>22954737</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>B-Raf V600E kinase domain in complex with an aminoisoquinoline inhibitor</PDB_Title>
      <PDB_ID>3IDP</PDB_ID>
      <Resolution>2.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3IDP</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD00450021</ASD_Ligand>
      <PubMed_Title>Selective inhibitors of the mutant B-Raf pathway: discovery of a potent and orally bioavailable aminoisoquinoline.</PubMed_Title>
      <Author>Smith AL, et al.</Author>
      <Journal>J Med Chem. 2009 Oct 22;52(20):6189-92.</Journal>
      <PubMed_ID>19764794</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>B-Raf Kinase in Complex with PLX4720</PDB_Title>
      <PDB_ID>3C4C</PDB_ID>
      <Resolution>2.57</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3C4C</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity.</PubMed_Title>
      <Author>Tsai J, et al.</Author>
      <Journal>Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3041-6.</Journal>
      <PubMed_ID>18287029</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>B-Raf V600E Kinase Domain Bound to a Type II Dihydroquinazoline Inhibitor</PDB_Title>
      <PDB_ID>4G9R</PDB_ID>
      <Resolution>3.2</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4G9R</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD00450020</ASD_Ligand>
      <PubMed_Title>Pyrazolopyridine inhibitors of B-Raf(V600E). Part 4: Rational design and kinase selectivity profile of cell potent type II inhibitors.</PubMed_Title>
      <Author>Wenglowsky, S., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2012)22:6237-6241</Journal>
      <PubMed_ID>22954737</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Human Kinase Domain of B-raf with a DFG-out Inhibitor</PDB_Title>
      <PDB_ID>4FC0</PDB_ID>
      <Resolution>2.95</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4FC0</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD00450019</ASD_Ligand>
      <PubMed_Title>Design and synthesis of novel DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitors: 3. Evaluation of 5-amino-linked thiazolo[5,4-d]pyrimidine and thiazolo[5,4-b]pyridine derivatives.</PubMed_Title>
      <Author>Hirose, M., et al.</Author>
      <Journal>Bioorg.Med.Chem.(2012)20:5600-5615</Journal>
      <PubMed_ID>22883026</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX3203</PDB_Title>
      <PDB_ID>3C4D</PDB_ID>
      <Resolution>2.65</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3C4D</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity.</PubMed_Title>
      <Author>Tsai J, et al.</Author>
      <Journal>Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3041-6.</Journal>
      <PubMed_ID>18287029</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Pyrazole-based inhibitors of B-Raf kinase</PDB_Title>
      <PDB_ID>3D4Q</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3D4Q</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Potent and selective pyrazole-based inhibitors of B-Raf kinase.</PubMed_Title>
      <Author>Hansen JD, et al.</Author>
      <Journal>Bioorg Med Chem Lett. 2008 Aug 15;18(16):4692-5.</Journal>
      <PubMed_ID>18676143</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>B-Raf kinase domain in complex with a tetrahydronaphthalene inhibitor</PDB_Title>
      <PDB_ID>3Q96</PDB_ID>
      <Resolution>3.1</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3Q96</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD00450016</ASD_Ligand>
      <PubMed_Title>Design and optimization of potent and orally bioavailable tetrahydronaphthalene raf inhibitors.</PubMed_Title>
      <Author>Gould, A.E., et al.</Author>
      <Journal>J.Med.Chem.(2011)54:1836-1846</Journal>
      <PubMed_ID>21341678</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of the Kinase domain of Human B-raf with a [1,3]thiazolo[5,4-b]pyridine derivative</PDB_Title>
      <PDB_ID>4DBN</PDB_ID>
      <Resolution>3.15</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4DBN</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD00450017</ASD_Ligand>
      <PubMed_Title>Design and synthesis of novel DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitors. 1. Exploration of [5,6]-fused bicyclic scaffolds.</PubMed_Title>
      <Author>Okaniwa, M., et al.</Author>
      <Journal>J.Med.Chem.(2012)55:3452-3478</Journal>
      <PubMed_ID>22376051</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Pim-1 Kinase Domain in Complex with 3-aminophenyl-7-azaindole</PDB_Title>
      <PDB_ID>3C4E</PDB_ID>
      <Resolution>1.98</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3C4E</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity.</PubMed_Title>
      <Author>Tsai J, et al.</Author>
      <Journal>Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3041-6.</Journal>
      <PubMed_ID>18287029</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>B-Raf Kinase in Complex with Birb796</PDB_Title>
      <PDB_ID>4JVG</PDB_ID>
      <Resolution>3.09</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4JVG</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD00740009</ASD_Ligand>
      <PubMed_Title>Inhibitors that stabilize a closed RAF kinase domain conformation induce dimerization.</PubMed_Title>
      <Author>Lavoie, H., et al.</Author>
      <Journal>Nat.Chem.Biol.(2013)9:428-436</Journal>
      <PubMed_ID>23685672</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THE COMPLEX OF MUTANT V599E B-RAF AND BAY439006</PDB_Title>
      <PDB_ID>1UWJ</PDB_ID>
      <Resolution>3.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1UWJ</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD00450013</ASD_Ligand>
      <Ligand_Name>4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}- N
-METHYLPYRIDINE-2-CARBOXAMIDE</Ligand_Name>
      <PubMed_Title>Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.</PubMed_Title>
      <Author>Wan PT, et al.</Author>
      <Journal>Cell. 2004 Mar 19;116(6):855-67.</Journal>
      <PubMed_ID>15035987</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of the B-Raf kinase domain bound to SB-590885</PDB_Title>
      <PDB_ID>2FB8</PDB_ID>
      <Resolution>2.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2FB8</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Demonstration of a genetic therapeutic index for tumors expressing oncogenic BRAF by the kinase inhibitor SB-590885.</PubMed_Title>
      <Author>King AJ, et al.</Author>
      <Journal>Cancer Res. 2006 Dec 1;66(23):11100-5.</Journal>
      <PubMed_ID>17145850</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THE COMPLEX OF WILD TYPE B-RAF AND BAY439006</PDB_Title>
      <PDB_ID>1UWH</PDB_ID>
      <Resolution>2.95</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1UWH</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD00450013</ASD_Ligand>
      <Ligand_Name>4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}- N
-METHYLPYRIDINE-2-CARBOXAMIDE</Ligand_Name>
      <PubMed_Title>Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.</PubMed_Title>
      <Author>Wan PT, et al.</Author>
      <Journal>Cell. 2004 Mar 19;116(6):855-67.</Journal>
      <PubMed_ID>15035987</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko04730</Pathway_ID>
      <Pathway_Title>Long-term depression</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05213</Pathway_ID>
      <Pathway_Title>Endometrial cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04015</Pathway_ID>
      <Pathway_Title>Rap1 signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05210</Pathway_ID>
      <Pathway_Title>Colorectal cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04914</Pathway_ID>
      <Pathway_Title>Progesterone-mediated oocyte maturation</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05214</Pathway_ID>
      <Pathway_Title>Glioma</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05212</Pathway_ID>
      <Pathway_Title>Pancreatic cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05221</Pathway_ID>
      <Pathway_Title>Acute myeloid leukemia</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05214</Pathway_ID>
      <Pathway_Title>Glioma</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05220</Pathway_ID>
      <Pathway_Title>Chronic myeloid leukemia</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05215</Pathway_ID>
      <Pathway_Title>Prostate cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04720</Pathway_ID>
      <Pathway_Title>Long-term potentiation</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05216</Pathway_ID>
      <Pathway_Title>Thyroid cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04510</Pathway_ID>
      <Pathway_Title>Focal adhesion</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cellular commiunity</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04068</Pathway_ID>
      <Pathway_Title>FoxO signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05160</Pathway_ID>
      <Pathway_Title>Hepatitis C</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05034</Pathway_ID>
      <Pathway_Title>Alcoholism</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Substance dependence</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05211</Pathway_ID>
      <Pathway_Title>Renal cell carcinoma</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05205</Pathway_ID>
      <Pathway_Title>Proteoglycans in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05223</Pathway_ID>
      <Pathway_Title>Non-small cell lung cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05200</Pathway_ID>
      <Pathway_Title>Pathways in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05216</Pathway_ID>
      <Pathway_Title>Thyroid cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04910</Pathway_ID>
      <Pathway_Title>Insulin signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04650</Pathway_ID>
      <Pathway_Title>Natural killer cell mediated cytotoxicity</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05034</Pathway_ID>
      <Pathway_Title>Alcoholism</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Substance dependence</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04722</Pathway_ID>
      <Pathway_Title>Neurotrophin signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04024</Pathway_ID>
      <Pathway_Title>cAMP signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04010</Pathway_ID>
      <Pathway_Title>MAPK signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05218</Pathway_ID>
      <Pathway_Title>Melanoma</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04726</Pathway_ID>
      <Pathway_Title>Serotonergic synapse</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04012</Pathway_ID>
      <Pathway_Title>ErbB signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04150</Pathway_ID>
      <Pathway_Title>mTOR signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04722</Pathway_ID>
      <Pathway_Title>Neurotrophin signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04270</Pathway_ID>
      <Pathway_Title>Vascular smooth muscle contraction</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Circulatory system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04810</Pathway_ID>
      <Pathway_Title>Regulation of actin cytoskeleton</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cell motility</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05219</Pathway_ID>
      <Pathway_Title>Bladder cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05205</Pathway_ID>
      <Pathway_Title>Proteoglycans in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04062</Pathway_ID>
      <Pathway_Title>Chemokine signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05218</Pathway_ID>
      <Pathway_Title>Melanoma</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05216</Pathway_ID>
      <Pathway_Title>Thyroid cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>Alpha and beta proteins (a+b)</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.e.daa.b.b.dg.html</SCOP_URL>
    <CATH_Class>Mixed alpha-beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/3c4d</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Detail>site,532,Cys;site,501,Glu;site,594,Asp;range,594,596,(DFG) loop;site,531,Trp;site,595,Phe;site,514,Leu;site,574,His;site,572,Ile;site,505,Leu;site,483,Lys;site,529,Thr</Site_Detail>
      <Site_Reference>Dietrich J, et al. Bioorg Med Chem. 2010,18(1):292-304.;Wan PT, et al. Cell. 2004,116(6):855-867.</Site_Reference>
      <Site_Type>Open-Close</Site_Type>
      <PDB_ID>1UWH;1UWJ</PDB_ID>
      <PubMed_ID>19962319;15035987</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>2.7.11.1</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC2/7/11/1.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD00450001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00450002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00450003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00450004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00450005</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00450006</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00450007</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00450008</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00450009</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00450010</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00450011</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00450012</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00450013</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00450016</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00450017</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00450019</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00450020</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00450021</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00450022</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00450023</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451005</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451006</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451007</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451008</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451009</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451010</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451011</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451012</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451013</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451014</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451015</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451016</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451017</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451018</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451019</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451020</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451021</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451022</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451023</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451024</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451025</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451026</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451027</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451028</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451029</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451030</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451031</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451032</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451033</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451034</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451035</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451036</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451037</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451038</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00451039</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00740009</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>